Heart, kidney, and metabolic health study in Shanghai
Part of Bones, joints & muscles, Heart & circulation, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at the link between heart, kidney, and metabolic health in adults living in Shanghai. It follows people who were part of an earlier health study to see how their health changes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a resident of a Shanghai community and part of a specific health study group (STONE cohort)
- You completed a health survey, physical exam, and lab tests between 2016 and 2017
- You have not moved away from your community for more than two years
- You can still be reached by phone or mail (contact info is current)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study tracks patients with heart disease, kidney disease, or metabolic conditions (like diabetes) over time to understand how these conditions connect and affect long-term health. By collecting medical records and health information, researchers aim to predict outcomes and improve care.
This study looks at people who may have a combination of heart disease, kidney problems, or metabolic issues like diabetes or high blood pressure. Researchers hope to learn more about these linked conditions to improve future care.
This study tests a program that uses WeChat to help people with metabolic syndrome and chronic kidney disease make healthy lifestyle changes. They want to see if this support can improve health and slow down kidney problems.
This trial tests if a personalized health coaching program can help people with metabolic syndrome and chronic kidney disease make lasting lifestyle changes. If you have both conditions and are not yet on dialysis, this program may help you manage your health.
This study tests a smartphone and wearable-based health management platform for people with early-stage cardiovascular-kidney-metabolic (CKM) syndrome. It aims to help patients track and improve their health through personalized support.
This study looks at how common cardiovascular-kidney-metabolic syndrome (CKM) is in people aged 30 to 79 living in Gaziantep, Turkey. It also checks how well certain risk scores predict health outcomes. You may join if you had certain blood tests in the last month.
Hear when a new Metabolic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.